SEC Form 4/A · accession 0001144204-16-118871
CALADRIUS BIOSCIENCES, INC. · CLBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Douglas W Losordo
Officer — See Remarks
Period of report
Aug 5, 2016
Accepted (ET)
Aug 12, 2016 · 6:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000320017
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 5, 2016 | A | 1,000 | $0.00 | A | 15,397 | D | |
| Common StockF1 | Aug 5, 2016 | F | 370 | $6.25 | D | 15,027 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 4,746 shares of unvested restricted stock.
Remarks
Senior Vice President, Clinical, Medical and Regulatory Affairs and Chief Medical Officer. All share numbers and per share prices disclosed in this Form 4 give effect to the Issuer's one-for-ten reverse stock split of its common stock effected on July 28, 2016. This amendment to Form 4 is being filed to reflect a disposition of 370 shares of common stock in satisfaction of the Reporting Person's tax withholding obligations.